Sergei Mechtcheriakov
Overview
Explore the profile of Sergei Mechtcheriakov including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
330
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mechtcheriakov S, Gleissenthall G, Geisler S, Arnhard K, Oberacher H, Schurr T, et al.
Alcohol Clin Exp Res
. 2022 Aug;
46(9):1648-1656.
PMID: 35938556
Background: Recent research has suggested that excessive alcohol consumption in patients with alcohol use disorder (AUD) is associated with chronic immune activation, which affects the metabolism of the neurotransmitter precursor...
2.
Faehrmann T, Zernig G, Mechtcheriakov S
Neuropsychiatr
. 2017 Jun;
32(1):1-8.
PMID: 28639210
One of the crucial purposes of treating alcohol-dependent patients is to enhance their ability to stay abstinent after detoxification therapy. Anxiety and stress vulnerability are the main factors provoking alcohol...
3.
Malik P, von Gleissenthall G, Gasser R, Moncayo R, Giesinger J, Mechtcheriakov S
Alcohol Clin Exp Res
. 2016 Apr;
40(6):1235-40.
PMID: 27061293
Background: Osteoprotegerin (OPG) is a parameter of increasing interest in the search for pathophysiological mechanisms of reduced bone mineral density (BMD). It has been shown to be increased in alcohol-dependent...
4.
Musalek M, Mechtcheriakov S, Yazdi K
Neuropsychiatr
. 2014 Dec;
28(4):218-21.
PMID: 25452115
No abstract available.
5.
Gleissenthall G, Geisler S, Malik P, Kemmler G, Benicke H, Fuchs D, et al.
Alcohol Alcohol
. 2014 Mar;
49(3):251-5.
PMID: 24644258
Aims: The aim of the study was to investigate the parameters of tryptophan and phenylalanine metabolism and their associations to immune system activation and to behavioural symptoms during medium-term withdrawal...
6.
Mechtcheriakov S, Rettenbacher M
Neuropsychiatr
. 2012 Nov;
26(4):187-91.
PMID: 23132685
Motivational Interviewing and associated communication techniques and intervention methods have been widely applied in patients with substance use disorder and other psychiatric disorders in the last twenty years. Intensive research...
7.
Krismer F, Roos J, Schranz M, Graziadei I, Mechtcheriakov S, Vogel W, et al.
Metab Brain Dis
. 2010 Sep;
25(3):285-95.
PMID: 20852922
Hepatic encephalopathy is a common complication of cirrhosis. The degree of neuro-psychiatric impairment is highly variable and its clinical staging subjective. We investigated whether eye movement response times-saccadic latencies-could serve...
8.
Marksteiner J, Kemmler G, Weiss E, Knaus G, Ullrich C, Mechtcheriakov S, et al.
Neurobiol Aging
. 2009 Apr;
32(3):539-40.
PMID: 19395124
Alzheimer's disease (AD) is a progressive neurodegenerative disorder with characteristic neuropathological changes of the brain. Great efforts have been undertaken to determine the progression of the disease and to monitor...
9.
Egger K, Schocke M, Weiss E, Auffinger S, Esterhammer R, Goebel G, et al.
Psychiatry Res
. 2008 Nov;
164(3):237-44.
PMID: 19013058
In this study, we explored to what extent brain abnormalities can be identified in specific brain structures of patients suffering from late onset depression. We examined the structural difference in...
10.
Mechtcheriakov S, Brenneis C, Egger K, Koppelstaetter F, Schocke M, Marksteiner J
J Neurol Neurosurg Psychiatry
. 2006 Nov;
78(6):610-4.
PMID: 17088334
Background: Patients with alcohol addiction show a number of transient or persistent neurological and psychiatric deficits. The complexity of these brain alterations suggests that several brain areas are involved, although...